Viewing Study NCT06343389



Ignite Creation Date: 2024-05-06 @ 8:20 PM
Last Modification Date: 2024-10-26 @ 3:25 PM
Study NCT ID: NCT06343389
Status: RECRUITING
Last Update Posted: 2024-07-09
First Post: 2024-03-25

Brief Title: Acute Kidney Injury in Patients With Liver Cirrhosis
Sponsor: Sohag University
Organization: Sohag University

Study Overview

Official Title: Study of Acute Kidney Injury in Patients With Liver Cirrhosis at Sohag University Hospital
Status: RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: In our locality limited studies have discussed AKI in patients with liver cirrhosis and its outcome therefore we aim to highlight the incidence patterns risk factors and outcomes of acute kidney injury in patients with liver cirrhosis at Sohag University Hospital
Detailed Description: Acute kidney injury AKI is a common condition in patients with cirrhosis It occurs in up to 50 of hospitalized patients with cirrhosis and in 58 of such patients in the intensive care unit AKI is one of the key predictors for short-term mortality in patients with liver cirrhosis with mortality rates as high as 90 There is a remarkable increase in length of hospital stay with high financial burden on patients with AKI

In general the three main causes of AKI are renal hypoperfusion also referred to as prerenal AKI which in most cases is due to hypovolemia intrinsic structural kidney injury and postrenal injury due to urinary obstruction A unique cause of AKI due to renal hypoperfusion in patients with cirrhosis is the hepatorenal syndrome HRS which is the result of renal vasoconstriction Early identification and management of AKI may improve outcomes

In our locality limited studies have discussed AKI in patients with liver cirrhosis and its outcome therefore we aim to highlight the incidence patterns risk factors and outcomes of acute kidney injury in patients with liver cirrhosis

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None